HUP9702463A2 - Eljárás és vegyületek anyagok magnetorelaxometriás kimutatásához és ezek alkalmazása - Google Patents
Eljárás és vegyületek anyagok magnetorelaxometriás kimutatásához és ezek alkalmazásaInfo
- Publication number
- HUP9702463A2 HUP9702463A2 HU9702463A HUP9702463A HUP9702463A2 HU P9702463 A2 HUP9702463 A2 HU P9702463A2 HU 9702463 A HU9702463 A HU 9702463A HU P9702463 A HUP9702463 A HU P9702463A HU P9702463 A2 HUP9702463 A2 HU P9702463A2
- Authority
- HU
- Hungary
- Prior art keywords
- magnetorelaxometric
- compounds
- analytes
- analysis
- determination
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000004451 qualitative analysis Methods 0.000 abstract 1
- 239000002002 slurry Substances 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 231100000027 toxicology Toxicity 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1875—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle coated or functionalised with an antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/72—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables
- G01N27/74—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids
- G01N27/745—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids for detecting magnetic beads used in biochemical assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y10S977/916—Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/927—Diagnostic contrast agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
- Y10S977/953—Detector using nanostructure
- Y10S977/96—Of magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Radiology & Medical Imaging (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Endocrinology (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A találmány tárgyai: eljárás anyagők magnetőrelaxőmetriás kvalitatívkiműtatására és/vagy kvantitatív meghatárőzására főlyadék- és szilárdfázisban; a magnetőrelaxőmetriás kiműtatásra szőlgáló vegyületek ésezek alkalmazása az analitikában és az imműnmagnetőgráfiában. A találmány szerinti eljárás és vegyületek különösen a termékenységivizsgálatőkban, a hisztőkőmpatibilitás meghatárőzásában, azallergőlógia, fertőző betegségek, higiénia, genetika, virőlógia,bakteriőlógia, tőxikőlógia, patőlógia, környezetvédelem és őrvősidiagnősztika területén alkalmazhatók. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19503664A DE19503664C2 (de) | 1995-01-27 | 1995-01-27 | Magnetorelaxometrische Detektion von Analyten |
PCT/EP1996/000339 WO1996023227A1 (de) | 1995-01-27 | 1996-01-29 | Verfahren und verbindungen zur magnetorelaxometrischen detektion von analyten und deren verwendung |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9702463A2 true HUP9702463A2 (hu) | 1998-04-28 |
HUP9702463A3 HUP9702463A3 (en) | 2000-03-28 |
HU221748B1 HU221748B1 (hu) | 2002-12-28 |
Family
ID=7753173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702463A HU221748B1 (hu) | 1995-01-27 | 1996-01-29 | Eljárás és vegyületek anyagok magnetorelaxometriás kimutatásához és ezek alkalmazása |
Country Status (22)
Country | Link |
---|---|
US (2) | US6027946A (hu) |
EP (1) | EP0805983B1 (hu) |
JP (1) | JP3607297B2 (hu) |
KR (1) | KR100412006B1 (hu) |
CN (1) | CN1176001A (hu) |
AT (1) | ATE188778T1 (hu) |
AU (1) | AU703069B2 (hu) |
CA (1) | CA2211364A1 (hu) |
DE (2) | DE19503664C2 (hu) |
DK (1) | DK0805983T3 (hu) |
ES (1) | ES2142569T3 (hu) |
FI (1) | FI973122A0 (hu) |
GR (1) | GR3033138T3 (hu) |
HU (1) | HU221748B1 (hu) |
IL (1) | IL116915A (hu) |
NO (1) | NO973444D0 (hu) |
NZ (1) | NZ301665A (hu) |
PT (1) | PT805983E (hu) |
RU (1) | RU2176393C2 (hu) |
UA (1) | UA54384C2 (hu) |
WO (1) | WO1996023227A1 (hu) |
ZA (1) | ZA96625B (hu) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19503664C2 (de) * | 1995-01-27 | 1998-04-02 | Schering Ag | Magnetorelaxometrische Detektion von Analyten |
DE19508772C2 (de) * | 1995-03-01 | 1998-01-29 | Schering Ag | Verfahren und Verbindungen zur Detektion von Analyten mittels Remanenzmessung und deren Verwendung |
DE19615254C2 (de) * | 1996-04-18 | 1999-03-11 | Diagnostikforschung Inst | Gerät zur höchstempfindlichen magnetischen Detektion von Analyten |
WO1998018497A2 (en) * | 1996-10-28 | 1998-05-07 | Nycomed Imaging As | Contrast agents |
US6437563B1 (en) * | 1997-11-21 | 2002-08-20 | Quantum Design, Inc. | Method and apparatus for making measurements of accumulations of magnetically susceptible particles combined with analytes |
EP1198712A2 (de) * | 1999-02-17 | 2002-04-24 | Kilian Hennes | Verfahren zum darstellen von biologisch aktivierten induktivitätsändernden partikeln sowie vorrichtung dafür |
JP4171139B2 (ja) * | 1999-07-21 | 2008-10-22 | 住友電気工業株式会社 | 磁性体標識による免疫検査方法とその装置 |
JP2003528289A (ja) * | 1999-08-06 | 2003-09-24 | インスティテュート・フュア・ディアグノスティクフォルシュンク・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・アン・デア・フライエン・ウニヴエアズィテート・ベルリン | 磁性粒子の二重屈折の緩和の測定を利用する結合反応を検出するための方法 |
US6979574B1 (en) * | 1999-08-06 | 2005-12-27 | Institut Fuer Diagnostik Forshung Gmbh | Process for detecting binding reactions with use of the measurement of the relaxation of the double refraction of magnetic particles |
DE19938372A1 (de) * | 1999-08-09 | 2001-03-08 | Diagnostikforschung Inst | Verfahren und Vorrichtung zur Trennung magnetischer Teilchen |
US6468809B1 (en) * | 2000-02-04 | 2002-10-22 | The United States Of America As Represented By The Secretary Of The Navy | High efficiency magnetic sensor for magnetic particles |
RU2166751C1 (ru) * | 2000-03-09 | 2001-05-10 | Никитин Петр Иванович | Способ анализа смеси биологических и/или химических компонентов с использованием магнитных частиц и устройство для его осуществления |
US20030076087A1 (en) * | 2001-08-31 | 2003-04-24 | Imego Ab | Method and arrangement relating to substance analysis |
US6825655B2 (en) * | 2001-08-31 | 2004-11-30 | Imego Ab | Method and arrangement for detecting changes of a magnetic response in magnetic particles |
WO2003019188A1 (en) | 2001-08-31 | 2003-03-06 | Imego Ab | Methdo and arrangement for analyzing substances |
EP1300684A1 (en) * | 2001-10-08 | 2003-04-09 | Barts and The London National Health Service Trust | Homogenous ligand binding assay |
US8697029B2 (en) * | 2002-04-18 | 2014-04-15 | The Regents Of The University Of Michigan | Modulated physical and chemical sensors |
GB0215185D0 (en) * | 2002-07-01 | 2002-08-07 | Genovision As | Binding a target substance |
US20040157219A1 (en) * | 2003-02-06 | 2004-08-12 | Jianrong Lou | Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
CN1829916B (zh) * | 2003-07-30 | 2010-09-29 | 皇家飞利浦电子股份有限公司 | 用于确定生物活性分子之间结合的磁性粒子的使用 |
US8118754B1 (en) | 2007-11-15 | 2012-02-21 | Flynn Edward R | Magnetic needle biopsy |
US8060179B1 (en) | 2006-11-16 | 2011-11-15 | Scientific Nanomedicine, Inc. | Biomagnetic detection and treatment of Alzheimer's Disease |
JP3962385B2 (ja) | 2004-03-11 | 2007-08-22 | 株式会社日立製作所 | 免疫検査装置及び免疫検査方法 |
US20050239091A1 (en) * | 2004-04-23 | 2005-10-27 | Collis Matthew P | Extraction of nucleic acids using small diameter magnetically-responsive particles |
US7892817B2 (en) * | 2004-05-18 | 2011-02-22 | Koninklijke Philips Electronics, N.V. | Magnetic rotation to improve signal-over-background in biosensing |
CA2575446C (en) * | 2004-08-03 | 2014-03-25 | Becton, Dickinson And Company | Use of magnetic material to direct isolation of compounds and fractionation of multipart samples |
US7719265B2 (en) * | 2004-11-17 | 2010-05-18 | Honda Motor Co., Ltd. | Methods for determining particle size of metal nanocatalyst for growing carbon nanotubes |
US9964469B2 (en) | 2005-02-28 | 2018-05-08 | Imagion Biosystems, Inc. | Magnetic needle separation and optical monitoring |
US20080093219A1 (en) * | 2005-03-15 | 2008-04-24 | Tufts University | Magnetic Protein Nanosensors and Methods of Use |
US20070020699A1 (en) * | 2005-07-19 | 2007-01-25 | Idexx Laboratories, Inc. | Lateral flow assay and device using magnetic particles |
US8735142B2 (en) * | 2005-08-16 | 2014-05-27 | Chipotle Business Group, Inc. | Systems and methods for immunosorbent assays for single and multiple analytes |
US7767404B2 (en) * | 2005-08-16 | 2010-08-03 | Chipotle Business Group, Inc. | Apparatus and method for single-step immunosorbent assay for single and multiple analytes |
DE102006003177A1 (de) * | 2006-01-23 | 2007-08-02 | Siemens Ag | Vorrichtung und Verfahren zum Nachweis eines Analyten |
SE529474C2 (sv) * | 2006-04-19 | 2007-08-21 | Imego Ab | Detekteringsanordning och förfarande |
US8447379B2 (en) | 2006-11-16 | 2013-05-21 | Senior Scientific, LLC | Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof |
US9068977B2 (en) * | 2007-03-09 | 2015-06-30 | The Regents Of The University Of Michigan | Non-linear rotation rates of remotely driven particles and uses thereof |
AT503845B1 (de) * | 2007-04-11 | 2008-03-15 | Arc Austrian Res Centers Gmbh | Optische messverfahren zur molekularen detektion anhand von relaxationsmessungen in optisch anisotropen nanopartikeln |
JP5205807B2 (ja) | 2007-05-17 | 2013-06-05 | 株式会社日立製作所 | 磁気信号計測装置 |
ES2665280T3 (es) * | 2007-06-29 | 2018-04-25 | Becton, Dickinson And Company | Métodos para la extracción y purificación de componentes de muestras biológicas |
EP2217928B1 (en) * | 2007-12-04 | 2017-08-09 | Pacific Biosciences of California, Inc. | Alternate labeling strategies for single molecule sequencing |
DE102008013997B4 (de) | 2008-03-13 | 2012-10-31 | Bundesrepublik Deutschland, vertr. durch d. Bundesministerium f. Wirtschaft und Technologie, dieses vertreten durch d. Präsidenten d. Physikalisch-Technischen Bundesanstalt | Verfahren zum quantitativen Nachweis von Analyten in flüssigem Medium |
US8241854B2 (en) * | 2008-05-22 | 2012-08-14 | California Institute Of Technology | Triggered RNAi |
US9167983B2 (en) * | 2008-08-15 | 2015-10-27 | The University Of Houston System | Imaging method for obtaining spatial distribution of nanoparticles in the body |
US9081004B2 (en) * | 2009-09-28 | 2015-07-14 | International Business Machines Corporation | Circuit for detecting analytes via nanoparticle-labeled substances with electromagnetic read-write heads |
AU2010315007B2 (en) | 2009-11-06 | 2015-05-21 | Imagion Biosystems, Inc. | Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof |
US10194825B2 (en) | 2009-11-06 | 2019-02-05 | Imagion Biosystems Inc. | Methods and apparatuses for the localization and treatment of disease such as cancer |
WO2012027747A2 (en) | 2010-08-27 | 2012-03-01 | The Regents Of The University Of Michigan | Asynchronous magnetic bead rotation sensing systems and methods |
US8409807B2 (en) | 2010-10-22 | 2013-04-02 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
CA2815085C (en) | 2010-10-22 | 2022-06-21 | T2 Biosystems, Inc. | Nmr systems and methods for the rapid detection of analytes |
DE102010043276A1 (de) * | 2010-11-03 | 2012-05-03 | Siemens Aktiengesellschaft | Magnetische Zelldetektion |
US9304130B2 (en) | 2010-12-16 | 2016-04-05 | International Business Machines Corporation | Trenched sample assembly for detection of analytes with electromagnetic read-write heads |
WO2012142179A2 (en) | 2011-04-11 | 2012-10-18 | The Regents Of The University Of Michigan | Magnetically induced microspinning for super-detection and super-characterization of biomarkers and live cells |
US8855957B2 (en) | 2011-05-03 | 2014-10-07 | International Business Machines Corporation | Method for calibrating read sensors of electromagnetic read-write heads |
US9040311B2 (en) | 2011-05-03 | 2015-05-26 | International Business Machines Corporation | Calibration assembly for aide in detection of analytes with electromagnetic read-write heads |
RU2497128C2 (ru) * | 2011-12-30 | 2013-10-27 | Федеральное Государственное Автономное Образовательное Учреждение Высшего Профессионального Образования "Сибирский Федеральный Университет" | Способ одновременного определения двух аналитов биолюминесцентным молекулярным микроанализом |
US20130289383A1 (en) * | 2012-04-27 | 2013-10-31 | Edward R. Flynn | Magnetic Relaxometry using Brownian Randomization, Neel Relaxation, or Combinations Thereof |
US9797817B2 (en) | 2012-05-03 | 2017-10-24 | The Regents Of The University Of Michigan | Multi-mode separation for target detection |
US9435800B2 (en) | 2012-09-14 | 2016-09-06 | International Business Machines Corporation | Sample assembly with an electromagnetic field to accelerate the bonding of target antigens and nanoparticles |
US9983110B2 (en) | 2013-11-04 | 2018-05-29 | The Regents Of The University Of Michigan | Asynchronous magnetic bead rotation (AMBR) microviscometer for analysis of analytes |
US10338029B2 (en) * | 2014-12-10 | 2019-07-02 | General Electric Company | Systems and methods for improved physiological monitoring |
CN104614513B (zh) * | 2015-01-26 | 2016-05-25 | 国家纳米科学中心 | 一种基于磁分离的弛豫时间免疫传感分析方法 |
DE102015225849A1 (de) * | 2015-12-18 | 2017-06-22 | Robert Bosch Gmbh | Verfahren zum Nachweis von Partikeln in einer Probe, Nachweisvorrichtung und mikrofluidisches System zum Untersuchen einer Probe |
WO2017127731A1 (en) | 2016-01-21 | 2017-07-27 | T2 Biosystems, Inc. | Nmr methods and systems for the rapid detection of bacteria |
CN106518598A (zh) * | 2016-10-09 | 2017-03-22 | 大连理工大学 | 采用n、n‑二甲基乙酰胺溶剂纯化正己烷的装置及方法 |
WO2019068204A1 (en) * | 2017-10-06 | 2019-04-11 | Jin Zhang | BIOCATORS BASED ON GIANT MAGNETORESISTANCE |
CN111208287B (zh) * | 2020-01-16 | 2022-07-26 | 长沙理工大学 | 一种磁共振传感器的构建方法 |
US11136543B1 (en) | 2020-02-11 | 2021-10-05 | Edward R. Flynn | Magnetic cell incubation device |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863713A (en) * | 1986-06-23 | 1989-09-05 | The Board Of Trustees Of Leland Stanford Jr. Univ. | Method and system for administering therapeutic and diagnostic agents |
JP2938918B2 (ja) * | 1990-01-25 | 1999-08-25 | ティーディーケイ株式会社 | 磁気微粒子の粒度測定方法 |
GB9007408D0 (en) * | 1990-04-02 | 1990-05-30 | Nycomed As | Compositions |
US5164297A (en) * | 1990-05-03 | 1992-11-17 | Advanced Magnetics Inc. | Solvent mediated relaxation assay system |
GB9120508D0 (en) * | 1991-09-26 | 1991-11-06 | Nycomed As | Diagnostic agents |
DE4309333A1 (de) * | 1993-03-17 | 1994-09-22 | Silica Gel Gmbh | Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben |
DE19503664C2 (de) * | 1995-01-27 | 1998-04-02 | Schering Ag | Magnetorelaxometrische Detektion von Analyten |
-
1995
- 1995-01-27 DE DE19503664A patent/DE19503664C2/de not_active Expired - Fee Related
-
1996
- 1996-01-26 ZA ZA96625A patent/ZA96625B/xx unknown
- 1996-01-26 IL IL11691596A patent/IL116915A/xx not_active IP Right Cessation
- 1996-01-29 KR KR1019970705107A patent/KR100412006B1/ko not_active IP Right Cessation
- 1996-01-29 AT AT96902934T patent/ATE188778T1/de not_active IP Right Cessation
- 1996-01-29 EP EP96902934A patent/EP0805983B1/de not_active Expired - Lifetime
- 1996-01-29 HU HU9702463A patent/HU221748B1/hu not_active IP Right Cessation
- 1996-01-29 UA UA97084369A patent/UA54384C2/uk unknown
- 1996-01-29 CA CA002211364A patent/CA2211364A1/en not_active Abandoned
- 1996-01-29 DE DE59604171T patent/DE59604171D1/de not_active Expired - Lifetime
- 1996-01-29 ES ES96902934T patent/ES2142569T3/es not_active Expired - Lifetime
- 1996-01-29 NZ NZ301665A patent/NZ301665A/xx unknown
- 1996-01-29 WO PCT/EP1996/000339 patent/WO1996023227A1/de active IP Right Grant
- 1996-01-29 JP JP52263896A patent/JP3607297B2/ja not_active Expired - Fee Related
- 1996-01-29 US US08/875,418 patent/US6027946A/en not_active Expired - Fee Related
- 1996-01-29 DK DK96902934T patent/DK0805983T3/da active
- 1996-01-29 PT PT96902934T patent/PT805983E/pt unknown
- 1996-01-29 AU AU47149/96A patent/AU703069B2/en not_active Ceased
- 1996-01-29 RU RU97114745/14A patent/RU2176393C2/ru not_active IP Right Cessation
- 1996-01-29 CN CN96191613A patent/CN1176001A/zh active Pending
-
1997
- 1997-07-25 NO NO973444A patent/NO973444D0/no not_active Application Discontinuation
- 1997-07-25 FI FI973122A patent/FI973122A0/fi not_active IP Right Cessation
-
1999
- 1999-09-03 US US09/389,223 patent/US6485985B1/en not_active Expired - Fee Related
-
2000
- 2000-04-04 GR GR20000400831T patent/GR3033138T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE19503664A1 (de) | 1996-08-01 |
NO973444L (no) | 1997-07-25 |
EP0805983A1 (de) | 1997-11-12 |
FI973122A (fi) | 1997-07-25 |
NO973444D0 (no) | 1997-07-25 |
WO1996023227A1 (de) | 1996-08-01 |
DE19503664C2 (de) | 1998-04-02 |
KR100412006B1 (ko) | 2005-09-30 |
CA2211364A1 (en) | 1996-08-01 |
UA54384C2 (uk) | 2003-03-17 |
DK0805983T3 (da) | 2000-04-25 |
MX9705543A (es) | 1997-10-31 |
ES2142569T3 (es) | 2000-04-16 |
AU4714996A (en) | 1996-08-14 |
PT805983E (pt) | 2000-04-28 |
IL116915A0 (en) | 1996-05-14 |
HU221748B1 (hu) | 2002-12-28 |
KR19980701711A (ko) | 1998-06-25 |
EP0805983B1 (de) | 2000-01-12 |
GR3033138T3 (en) | 2000-08-31 |
ATE188778T1 (de) | 2000-01-15 |
US6485985B1 (en) | 2002-11-26 |
ZA96625B (en) | 1997-07-21 |
HUP9702463A3 (en) | 2000-03-28 |
IL116915A (en) | 2000-12-06 |
FI973122A0 (fi) | 1997-07-25 |
AU703069B2 (en) | 1999-03-11 |
US6027946A (en) | 2000-02-22 |
JPH10513551A (ja) | 1998-12-22 |
NZ301665A (en) | 1999-03-29 |
CN1176001A (zh) | 1998-03-11 |
RU2176393C2 (ru) | 2001-11-27 |
DE59604171D1 (de) | 2000-02-17 |
JP3607297B2 (ja) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9702463A2 (hu) | Eljárás és vegyületek anyagok magnetorelaxometriás kimutatásához és ezek alkalmazása | |
ES2112057T3 (es) | Metodo de deteccion y/o cuantificacion y/o separacion de celulas apoptosicas dentro de o en una muestra. | |
TR200000113T2 (tr) | Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri. | |
CA2412121A1 (en) | Method for the detection of influenza a/b viruses | |
MX9801687A (es) | Compuestos y metodos para el diagnostico de tuberculosis. | |
ES2114727T3 (es) | Inmunoensayo rapido para deteccion de anticuerpos o antigenos que incorpora extraccion de la muestra y reaccion inmunogena simultaneas. | |
WO1996007761A3 (en) | Method for testing for mutations in dna from a patient sample | |
DE59108006D1 (de) | Vorrichtung zur Vorbereitung von Proben insbesondere für Analysezwecke | |
AU3538195A (en) | Assays and devices for the detection of extrahepatic biliary atresia | |
DE69428958D1 (de) | Vorrichtung zum Sammeln und in-vitro-Transport von Proben, insbesondere für Diagnoseverwendungen | |
BR8906988A (pt) | Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico | |
JP2002504222A (ja) | 抗原の in situ 免疫検出 | |
IT1291913B1 (it) | Metodo che prevede l'uso di batteriofagi per la rivelazione della presenza di molecole di interesse in campioni biologici | |
CA2385830A1 (en) | Probe for protein-protein interaction analysis, and method of using it for analysis of protein-protein interaction | |
IT7922812A0 (it) | Dispositivo composito perl'esercizio positivo di segnaletica stradale, e metodo per la sua utilizzazione. | |
ATE397215T1 (de) | Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind | |
MX9706437A (es) | Proceso y compuestos para la deteccion de analitos usando medicion de remanencia y el uso de los mismos. | |
WO2002015559A3 (en) | High-resolution digital image processing in the analysis of pathological materials | |
PT100731A (pt) | Estojo de imunoensaio para a deteccao simultanea de anticorpos de hiv-1,hiv-2,htlv-i e htlv-ii e metodo para a sua preparacao | |
KR100270632B1 (ko) | 표적 항원을 검출하기 위한 동일계 면역 검정 킷 | |
SE8901127D0 (sv) | Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras | |
DE69731388D1 (de) | Nukleinsäure-fragmente, die spezifische für die mitglieder des m. tuberculosis komplexes sind, deren anwendung zur detektion und differentiale diagnose der mitglieder des m. tuberculosis komplexes | |
CA2213083A1 (en) | Detection of antibody production | |
IE40645B1 (en) | Visual method for the detection of syphilis and other treponemal diseases, and an antigen preparation useful therein | |
RU2000127463A (ru) | Способ качественного определения гомеопатического лекарственного препарата или потенцированной формы вещества |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |